艾乐替尼是一种口服药物，阻断间变性淋巴瘤激酶（ALK）[3][4]的活性，并用于治疗非小细胞肺癌（NSCLC）。
4-Chloro-3-nitrobenzonitrile
7-Methoxy-1,1-dimethyl-3,4-dihydronaphthalen-2(1H)-one
tert-Butyl 6-cyano-2-(2-(4-ethyl-3-iodophenyl)propan-2-yl)-1H-indole-3-carboxylate
Ethynyltriisopropylsilane
7-Methoxy-3,4-dihydronaphthalen-2(1H)-one
2-(4-Ethylphenyl)-2-methylpropanoic acid
2-(4-Ethyl-3-iodophenyl)-2-methylpropanoic acid
3-tert-Butoxy-3-oxopropanoic acid
4-Morpholinopiperidine
9-Ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-5H-benzo[B]carbazole-3-carbonitrile,hydrochloride
Potassium trifluoro(vinyl)borate
2-(4-Bromophenyl)-2-methylpropanoic acid
6-Cyanoindole
2-Methyl-2-(4-vinylphenyl)propanoic acid
6-Cyano-2-(2-(4-ethyl-3-(4-morpholinopiperidin-1-yl)phenyl)propan-2-yl)-1H-indole-3-carboxylic acid
3-Hydrazinylbenzonitrile
6-Bromo-7-methoxy-1,1-dimethyl-3,4-dihydronaphthalen-2(1H)-one
Methyl 6-cyano-1H-indole-3-carboxylate
9-Bromo-8-hydroxy-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile
9-bromo-8-methoxy-6,6-dimethyl-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile
1-(3-Bromo-4-ethylphenyl)ethanone
9-Bromo-8-methoxy-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile
tert-Butyl 6-cyano-2-(2-(4-ethyl-3-(4-morpholinopiperidin-1-yl)phenyl)propan-2-yl)-1H-indole-3-carboxylate
